DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more



Prophylactic Antibiotics for Manual Removal of Retained Placenta in Vaginal Birth: a Randomized Controlled Trial

Information source: Hadassah Medical Organization
ClinicalTrials.gov processed this data on August 23, 2015
Link to the current ClinicalTrials.gov record.

Condition(s) targeted: Endometritis

Intervention: Antibiotic prophylaxis (Drug); Ampicillin (Drug); Gentamycin (Drug); Clindamycin (Drug)

Phase: N/A

Status: Not yet recruiting

Sponsored by: Hadassah Medical Organization

Overall contact:
Hadas Lamnerg, MD, Phone: : 00 972 2 6777572, Email: lhadas@hadassah.org.il

Summary

Background: There is scarce evidence regarding the necessity of antibiotic prophylaxis in manual revision of the uterus after labor in cases of residual placenta. Methods: a randomized control trial in which parturients for which the placenta was not separated or there is a suspected residual placenta will be divided randomly to two groups: (1) Revision of uterus or Manual lysis without antibiotic prophylaxis; (2) Revision of uterus or Manual lysis with antibiotic prophylaxis as following: 24 hours coverage with Ampicillin 2 grams*4, Gentamycin 240 mg*1, Clindamycin 600 mg*3. In cases of allergy to Penicillin the antibiotic regimen will be: Gentamycin 240 mg*1, Clindamycin 600 mg*3. Outcomes: Puerperal fever, endometritis, length of hospitalization after labor, recurrent hospitalization in the first 2 weeks after discharge.

Clinical Details

Official title: Prophylactic Antibiotics for Manual Removal of Retained Placenta in Vaginal Birth

Study design: Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment

Primary outcome: Endometritis rate

Secondary outcome: Puerperal fever

Eligibility

Minimum age: 15 Years. Maximum age: 50 Years. Gender(s): Female.

Criteria:

Inclusion Criteria:

- suspected retained placenta

Exclusion Criteria:

- Intrapartum fever

Locations and Contacts

Hadas Lamnerg, MD, Phone: : 00 972 2 6777572, Email: lhadas@hadassah.org.il

Hadassah Medical Organization, Jerusalem, Israel; Not yet recruiting
Additional Information

Starting date: January 2014
Last updated: November 26, 2013

Page last updated: August 23, 2015

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017